Aim. Despite the fact that the pituitary adenoma is a relatively benign tumor, sometimes the course of the disease is complicated by intramedullary hemorrhage. In the world literature there are single data on the molecular mechanism of hemorrhage in the adenomas of the pituitary gland. Vascular endothelial growth factor (VEGF) plays an important role in angiogenesis and permeability of the endothelium in various brain tumors. There was made an analysis of the relationship between pituitary apoplexy and VEGF expression in pituitary adenomas. Material and methods. Immunohistochemical investigation of the level of expression of the molecular-biological marker - VEGF was performed with the use of monoclonal antibodies with the method of semiquantitative analysis in 30 pituitary adenoma patients. In the clinical study data about the age, gender, hormonal activity and X-ray study were studied. There was executed a statistical analysis of the relationship between clinical diagnostic data and VEGF expression. Results. Hormonal active tumors were detected in 12 (40%) cases, intratumoral hemorrhage - in 16 (53.3%), adenomas with cystic component - in 7 (23.3%) and invasion of cavernous sinus - in 22 (73.3%) of cases. Expression of VEGF was observed in 11 cases (36.6%). Based on the analysis the expression of VEGF was found to be closely related to pituitary apoplexy (PA) in pituitary adenomas (p < 0.001). However, there was no statistically significant relationship between VEGF and age, sex, tumor size, hormonal activity, cystic component presence, invasive tumor growth (p > 0.05). Conclusion. It was found that immunohistochemical examination of the level of expression of a molecular biological marker VEGF can be used in the evaluation of the prognosis of the disease or the identification of a risk group with a high probability of the development of pituitary apoplexy and recurrence of tumor growth.

Full Text

Restricted Access

About the authors

K. E Makhkamov

Republican Research Centre of Emergency Medicine

Tashkent, 100115, Republic of Uzbekistan

Miralib M. Azizov

Republican Research Centre of Emergency Medicine

MD, Senior Researches of the Department of the Neurosurgery, Tashkent, 100115, Republic of Uzbekistan Tashkent, 100115, Republic of Uzbekistan

T. A Vervekina

Republican Research Centre of Emergency Medicine

Tashkent, 100115, Republic of Uzbekistan

D. A Nishonov

Republican Research Centre of Emergency Medicine

Tashkent, 100115, Republic of Uzbekistan


  1. Бабиченко И.И., Ковязин В.А. Новые методы иммуногистохимической диагностики опухолевого роста: Учебное пособие. М.: РУДН, 2008.
  2. Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treat. 1995; 36(2): 127-37.
  3. Kurihara N., Takahashi S., Higano S., Ikeda H., Mugikura S., Singh L.N. et al. Hemorrhage in pituitary adenoma: correlation of MR imaging with operative findings. Eur. Radiol. 1998; 8: 971-6.
  4. Connolly D.T. Vascular permeability factor a unique regulator of blood vessel function. J. Cell Biochem. 1991; 47: 219-23.
  5. Yamada S., Takada K. Angiogenesis in pituitary adenomas. Microsc. Res. Tech. 2003; 60: 236-43.
  6. Ke L.D., Shi Y.X., Yung W.K. VEGF, VEGF over expression enhances tumorigenicity in U251 MG but not in NG-1 glioma cells. Cancer Res. 2002; 62: 1854-61.
  7. Холова Д.Ш., Халимова З.Ю., Урманова Ю.М., Алиева Д.А., Алимухамедова Г.О. Состояние показателей процессов апоптоза и ангиогенеза у больных с неактивными аденомами гипофиза. Международный эндокринологический журнал. 2015; [6(70)]: 28-9.
  8. Mendiola M., Barriuso J., Redondo A. et al. Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma. PLoS One. 2008; 3: 4051.
  9. Jung S., Moon K.S., Jung T.Y., Kim I.Y., Lee Y.H., Rhu H.H. et al. Possible pathophysiological role of vascular endothelial growth factor(VEGF) and matrix metalloproteinase (MMPs) in metastatic brain tumor associated intracerebral hemorrhage. J. Neurooncol. 2006; 76: 257-63.
  10. Arita K., Kurisu K., Tominaga A., Sugiyama K., Eguchi K., Hama S. et al. Relationship between intratumoral hemorrhage and over expression of vascular endothelial growth factor(VEGF) in pituitary adenoma. Hiroshima J. Med.Sci. 2004; 53: 23-7.
  11. Fukui S., Otani N., Nawashiro H., Yano A., Nomura N., Tokumaru A.M. et al. The association of the expression of vascular endothelial growth factor with the cystic component and haemorrhage in pituitary adenoma. J. Clin. Neurosci. 2003; 10: 320-4.
  12. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999; 13: 9-22.
  13. Карамышева А.Ф. Механизмы ангиогенеза. Биохимия. 2008; 73(7): 935-48.
  14. Niveiro M., Aranda F.I., Peiro G., Alenda C., Pico A. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas. Hum. Pathol. 2005; 36: 1090-5.
  15. Adams J., Carder P.J., Downey S. et al. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res. 2000; 60(11): 2898-905.
  16. Kim J.H., Chung Y.G., Lee H.K., Lee K.C., Suh J.K.: Evaluation of cerebrospinal fluid vascular endothelial growth factor for the brain tumor. J. Korean Neurosurg. Soc. 2003; 33: 121-5.
  17. Cheng S.Y., Nagane M., Huang H.S., Cavenee W.K. Intracerebral tumor-associated hemorrhage caused by over expression of the vascular endothelial growth factor isoforms VEGF. Proc Natl. Acad. Sci. USA. 1997; 94: 12081-7.
  18. George L. Kumar, Lars Rudbeck. Иммуногистохимические методы: руководство. DAKO / Пер. с англ. под ред. Г.А. Франка, П.Г. Малькова. М., 2011.
  19. Knosp E., Steiner E., Kitz K., Matula C.: Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993; 33: 610-8.
  20. Biroccio A., Candiloro A., Mottolese M. et al. Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line. FASEB J. 2000; 14(5): 652-60.
  21. Esser S., Wolburg K., Wolberg H., Breier G., Kurzchalia T., Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 1998: 140(6): 947-59.



Abstract: 141

Article Metrics

Metrics Loading ...


  • There are currently no refbacks.

Copyright (c) 2017 Eco-Vector

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies